Results 131 to 140 of about 2,722,809 (208)

Body Mass Index Trajectories Among Patients with Drug-Susceptible and Drug-Resistant Tuberculosis in Northwest Ethiopia. [PDF]

Infect Dis Ther
Wagnew F, Alene KA, Kelly M, Gray D.
europepmc   +1 more source

Is targeted next generation sequencing for drug-resistant tuberculosis feasible in a high-burden setting: a qualitative study from Indonesia. [PDF]

BMJ Open
Annisa SN, Alifia A, Larasmanah AN, Ramadhani NS, Indriani S, Soeroto AY, van Crevel R, Hill PC, Lestari BW.   +8 more
europepmc   +1 more source

Preserved Spermatogenesis and Hormonal Function in Men Receiving a Pretomanid Regimen (BPaMZ) for Pulmonary Drug-Resistant Tuberculosis. [PDF]

Clin Pharmacol Ther
Howell P, Lombardi A, Brumskine W, Mikiashvili L, Boekelheide K, Moreira J, Holsta A, Betteridge M, Thompson L, Crook A, Bruinenberg P, Beumont M, Sun E, Conradie F.   +13 more
europepmc   +1 more source

Cohort evaluation of an all-oral shorter regimen for drug-resistant tuberculosis in Ecuador. [PDF]

BMC Infect Dis
Chacón A, Bustos YC, Martinez D, Chong F, Freile C, Ayala C, Seck A, Sall FB, Merle CS, Perez F.   +9 more
europepmc   +1 more source

Epidemiological Characteristics and Treatment Outcomes of Drug-Resistant Tuberculosis in Limpopo Province, South Africa (2020-2024). [PDF]

Trop Med Infect Dis
Rukasha I, Kaapu KG.
europepmc   +1 more source

A Short-Course Regimen Containing Delamanid, Bedaquiline and Linezolid for the Treatment of Drug-Resistant Tuberculosis: A Retrospective Study from China. [PDF]

Infect Drug Resist
Jin L, Zhang X, Jiang H, Li Q, Liu W, Wang J, Cao Z, Liu Y.   +7 more
europepmc   +1 more source

Adverse events in bedaquiline- and pretomanid-based regimens for drug-resistant tuberculosis from trial, implementation and pharmacovigilance studies. [PDF]

Br J Clin Pharmacol
Maria N, Larasati AL, Hamdani IY, Cho JG, Alffenaar JC.   +4 more
europepmc   +1 more source

Impact of diabetes mellitus on drug-resistant tuberculosis across resistance categories: a systematic review and meta-analysis. [PDF]

J Glob Health
Gou B, Wang J, Liu H, Lu S, Wang X.
europepmc   +1 more source

Burden of multidrug-resistant and extensively drug-resistant tuberculosis in China, India and Russia: estimates from the GBD 2023 study. [PDF]

J Thorac Dis
Li JD, Li ZY, Xiong KH, Ling JW, Chen GQ, Tang HH, Huang BB, Chen YT, Chen G, Ning Z, Feng H.   +10 more
europepmc   +1 more source

Drug-Resistant Tuberculosis Outcomes in South Kivu Province, Democratic Republic of Congo, During a Humanitarian Crisis (2018-2024). [PDF]

Open Forum Infect Dis
Musafiri EM, Kabesha BT, Birembano F, Nyota R, Mapendo MC, Chirambiza JP, Mosomo TK, Namegabe EN.   +7 more
europepmc   +1 more source